This group consists of small molecular entities that have been optimized to bind to certain biological targets and/or pathways. Pharmaceuticals of high quality are also provided in lab quantities for research and development needs.
| Structure | Details |
|---|---|
|
|
Name: Lorcaserin hydrochloride, 98%, a selective full agonist of human 5-HT2C receptor CAS: 846589-98-8 Order #: 50P1238240 Purity : 98% MF : C11H15Cl2N MW : 232.148 SDS |
|
|
Name: Ruxolitinib phosphate salt, 99% CAS: 1092939-17-7 Order #: 50P1349106 Purity : 99% MF : C17H21N6O4P MW : 404.367 SDS |
|
|
Name: Dabrafenib, 98%, a mutant BRAFV600 specific inhibitor CAS: 1195765-45-7 Order #: 50P1410144 Purity : 98% MF : C23H20F3N5O2S2 MW : 519.561 SDS |
|
|
Name: Afatinib dimaleate, 99% CAS: 850140-73-7 Order #: 50P1648192 Purity : 99% MF : C32H33ClFN5O11 MW : 718.088 SDS |
|
|
Name: Palbociclib hydrochloride, 99%, a highly selective CDK4/6 inhibitor CAS: 827022-32-2 Order #: 50P1761081 Purity : 99% MF : C24H30ClN7O2 MW : 484.001 SDS |